Cargando…
High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study
Autores principales: | Li, Jun, Han, Qi, Huang, Yanqing, Wei, Yanhui, Zi, Jie, Zhao, Lidong, Cai, Zhimei, Lu, Xuzhang, Xiao, Rong, Zhang, Yanming, Yang, Xiaotian, Xu, Hao, Sun, Naitong, Zhuang, Wanchuan, Wu, Zhengdong, Xia, Yuan, Xu, Yanli, He, Bin, Zhu, Wei, Min, Fengling, Chen, Yongchun, Ding, Banghe, Shi, Peimin, Xie, Jing, Tang, Hua, Liu, Zefa, Li, Bingzong, Sun, Yu, Qiu, Hongxia, Duan, Limin, Dovat, Elanora, Song, Chunhua, SzeKely, Laszlo, Dovat, Sinisa, Ge, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616883/ https://www.ncbi.nlm.nih.gov/pubmed/36307399 http://dx.doi.org/10.1038/s41408-022-00740-3 |
Ejemplares similares
-
Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia
por: Ge, Zheng, et al.
Publicado: (2016) -
P582: AZACITIDINE COMBINED WITH HAG REGIMEN AS INDUCTION THERAPY IN ADULT AML PATIENTS
por: Pan, Hong, et al.
Publicado: (2023) -
PB1784: CLADRIBINE SYNERGIZES THE EFFECT OF VENETOCLAX ON CELL PROLIFERATION ARREST AND APOPTOSIS BY TARGETING DNA-PKCS/C-MYC SIGNALING IN ACUTE MYELOID LEUKEMIA
por: Hou, Yue, et al.
Publicado: (2023) -
Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia
por: Gu, Siyu, et al.
Publicado: (2023) -
Increased Incidence of IKZF1 deletions and IGH-CRLF2 translocations in B-ALL of Hispanic/Latino children—a novel health disparity
por: Raca, Gordana, et al.
Publicado: (2021)